Amylmetacresol

CAS No. 1300-94-3

Amylmetacresol( Amylmetacresol )

Catalog No. M17931 CAS No. 1300-94-3

Amylmetacresol is used in the treatment of sore throat or ‘acute sore throat’, pharyngitis, tonsillitis and laryngitis. As well as in the treatment of influenza A and SARS-CoV.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 26 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Amylmetacresol
  • Note
    Research use only, not for human use.
  • Brief Description
    Amylmetacresol is used in the treatment of sore throat or ‘acute sore throat’, pharyngitis, tonsillitis and laryngitis. As well as in the treatment of influenza A and SARS-CoV.
  • Description
    Amylmetacresol is used as a Topical antiseptic for treatment of sore throat.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Amylmetacresol
  • Pathway
    Angiogenesis
  • Target
    Syk
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1300-94-3
  • Formula Weight
    178.27
  • Molecular Formula
    C12H18O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (560.95 mM)
  • SMILES
    CCCCCc1ccc(C)cc1O
  • Chemical Name
    6-Pentyl-m-cresol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mcnally D, et al, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques, 2012, 15(2):281.
molnova catalog
related products
  • ASN-002

    ASN-002 (Gusacitinib, ASN002) is a novel and potent dual inhibitor of SYK/JAK kinases with IC50 of 5-46 nM in biochemical assays.

  • Sovleplenib

    Sovleplenib (HMPL523) is an orally available, selective and potent inhibitor of the splenic tyrosine kinase SYK with an IC50 of 25 nM.Sovleplenib has antitumor activity and may be used in studies of immune thrombocytopenia (ITP).

  • R406

    R406 is a potent Syk inhibitor with IC50 of 41 nM, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 1.